Cargando…

[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a Tumor Imaging Agent

[Image: see text] Although the growth and proliferation of most tumors is fueled by glucose, some tumors are more likely to metabolize glutamine. In particular, tumor cells with the upregulated c-Myc gene are generally reprogrammed to utilize glutamine. We have developed new 3-fluoropropyl analogs o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zehui, Zha, Zhihao, Li, Genxun, Lieberman, Brian P., Choi, Seok Rye, Ploessl, Karl, Kung, Hank F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224545/
https://www.ncbi.nlm.nih.gov/pubmed/25095908
http://dx.doi.org/10.1021/mp500236y
_version_ 1782343373227556864
author Wu, Zehui
Zha, Zhihao
Li, Genxun
Lieberman, Brian P.
Choi, Seok Rye
Ploessl, Karl
Kung, Hank F.
author_facet Wu, Zehui
Zha, Zhihao
Li, Genxun
Lieberman, Brian P.
Choi, Seok Rye
Ploessl, Karl
Kung, Hank F.
author_sort Wu, Zehui
collection PubMed
description [Image: see text] Although the growth and proliferation of most tumors is fueled by glucose, some tumors are more likely to metabolize glutamine. In particular, tumor cells with the upregulated c-Myc gene are generally reprogrammed to utilize glutamine. We have developed new 3-fluoropropyl analogs of glutamine, namely [(18)F](2S,4R)- and [(18)F](2S,4S)-4-(3-fluoropropyl)glutamine, 3 and 4, to be used as probes for studying glutamine metabolism in these tumor cells. Optically pure isomers labeled with (18)F and (19)F (2S,4S) and (2S,4R)-4-(3-fluoropropyl)glutamine were synthesized via different routes and isolated in high radiochemical purity (≥95%). Cell uptake studies of both isomers showed that they were taken up efficiently by 9L tumor cells with a steady increase over a time frame of 120 min. At 120 min, their uptake was approximately two times higher than that of l-[(3)H]glutamine ([(3)H]Gln). These in vitro cell uptake studies suggested that the new probes are potential tumor imaging agents. Yet, the lower chemical yield of the precursor for 3, as well as the low radiochemical yield for 3, limits the availability of [(18)F](2S,4R)-4-(3-fluoropropyl)glutamine, 3. We, therefore, focused on [(18)F](2S,4S)-4-(3-fluoropropyl)glutamine, 4. The in vitro cell uptake studies suggested that the new probe, [(18)F](2S,4S)-4-(3-fluoropropyl)glutamine, 4, is most sensitive to the LAT transport system, followed by System N and ASC transporters. A dual-isotope experiment using l-[(3)H]glutamine and the new probe showed that the uptake of [(3)H]Gln into 9L cells was highly associated with macromolecules (>90%), whereas the [(18)F](2S,4S)-4-(3-fluoropropyl)glutamine, 4, was not (<10%). This suggests a different mechanism of retention. In vivo PET imaging studies demonstrated tumor-specific uptake in rats bearing 9L xenographs with an excellent tumor to muscle ratio (maximum of ∼8 at 40 min). [(18)F](2S,4S)-4-(3-fluoropropyl)glutamine, 4, may be useful for testing tumors that may metabolize glutamine related amino acids.
format Online
Article
Text
id pubmed-4224545
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-42245452015-08-05 [(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a Tumor Imaging Agent Wu, Zehui Zha, Zhihao Li, Genxun Lieberman, Brian P. Choi, Seok Rye Ploessl, Karl Kung, Hank F. Mol Pharm [Image: see text] Although the growth and proliferation of most tumors is fueled by glucose, some tumors are more likely to metabolize glutamine. In particular, tumor cells with the upregulated c-Myc gene are generally reprogrammed to utilize glutamine. We have developed new 3-fluoropropyl analogs of glutamine, namely [(18)F](2S,4R)- and [(18)F](2S,4S)-4-(3-fluoropropyl)glutamine, 3 and 4, to be used as probes for studying glutamine metabolism in these tumor cells. Optically pure isomers labeled with (18)F and (19)F (2S,4S) and (2S,4R)-4-(3-fluoropropyl)glutamine were synthesized via different routes and isolated in high radiochemical purity (≥95%). Cell uptake studies of both isomers showed that they were taken up efficiently by 9L tumor cells with a steady increase over a time frame of 120 min. At 120 min, their uptake was approximately two times higher than that of l-[(3)H]glutamine ([(3)H]Gln). These in vitro cell uptake studies suggested that the new probes are potential tumor imaging agents. Yet, the lower chemical yield of the precursor for 3, as well as the low radiochemical yield for 3, limits the availability of [(18)F](2S,4R)-4-(3-fluoropropyl)glutamine, 3. We, therefore, focused on [(18)F](2S,4S)-4-(3-fluoropropyl)glutamine, 4. The in vitro cell uptake studies suggested that the new probe, [(18)F](2S,4S)-4-(3-fluoropropyl)glutamine, 4, is most sensitive to the LAT transport system, followed by System N and ASC transporters. A dual-isotope experiment using l-[(3)H]glutamine and the new probe showed that the uptake of [(3)H]Gln into 9L cells was highly associated with macromolecules (>90%), whereas the [(18)F](2S,4S)-4-(3-fluoropropyl)glutamine, 4, was not (<10%). This suggests a different mechanism of retention. In vivo PET imaging studies demonstrated tumor-specific uptake in rats bearing 9L xenographs with an excellent tumor to muscle ratio (maximum of ∼8 at 40 min). [(18)F](2S,4S)-4-(3-fluoropropyl)glutamine, 4, may be useful for testing tumors that may metabolize glutamine related amino acids. American Chemical Society 2014-08-05 2014-11-03 /pmc/articles/PMC4224545/ /pubmed/25095908 http://dx.doi.org/10.1021/mp500236y Text en Copyright © 2014 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Wu, Zehui
Zha, Zhihao
Li, Genxun
Lieberman, Brian P.
Choi, Seok Rye
Ploessl, Karl
Kung, Hank F.
[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a Tumor Imaging Agent
title [(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a Tumor Imaging Agent
title_full [(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a Tumor Imaging Agent
title_fullStr [(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a Tumor Imaging Agent
title_full_unstemmed [(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a Tumor Imaging Agent
title_short [(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a Tumor Imaging Agent
title_sort [(18)f](2s,4s)-4-(3-fluoropropyl)glutamine as a tumor imaging agent
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224545/
https://www.ncbi.nlm.nih.gov/pubmed/25095908
http://dx.doi.org/10.1021/mp500236y
work_keys_str_mv AT wuzehui 18f2s4s43fluoropropylglutamineasatumorimagingagent
AT zhazhihao 18f2s4s43fluoropropylglutamineasatumorimagingagent
AT ligenxun 18f2s4s43fluoropropylglutamineasatumorimagingagent
AT liebermanbrianp 18f2s4s43fluoropropylglutamineasatumorimagingagent
AT choiseokrye 18f2s4s43fluoropropylglutamineasatumorimagingagent
AT ploesslkarl 18f2s4s43fluoropropylglutamineasatumorimagingagent
AT kunghankf 18f2s4s43fluoropropylglutamineasatumorimagingagent